T/CAQ 29017-2024 Active Group standards

T/CAQ 29017-2024 Quality Chinese medicinal herbs: Wild chrysanthemum

Publish Date: 2024-12-28 Implement Date: 2024-12-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CAQ 29017-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Chinese medicinal materials

ICS Name: Drugs

Publish Date: 2024-12-28

Implement Date: 2024-12-31

Scope

Scope: This document specifies the requirements, inspection methods, inspection rules, judgment rules, labeling, packaging, and storage for high-quality traditional Chinese medicine (TCM) material, Wild Chrysanthemum. This document is applicable to the assessment of high-quality Wild Chrysanthemum TCM materials. Main technical content: Wild Chrysanthemum is a commonly used traditional Chinese medicine in China, with the functions of clearing heat and detoxifying, purging fire and calming the liver, and has high medicinal value. The *Pharmacopoeia of the People's Republic of China* (2020 Edition) (hereinafter referred to as the *Chinese Pharmacopoeia*) stipulates requirements such as "appearance," "identification," "inspection," and "content determination" for Wild Chrysanthemum materials, along with limit indicators for 33 prohibited pesticides. These constitute the "basic" standards for Wild Chrysanthemum TCM materials. However, their quality standards cannot meet the diverse market demands for Wild Chrysanthemum, making it an inevitable requirement for quality grading management to establish standards for high-quality Wild Chrysanthemum TCM materials. This document proposes high-quality Wild Chrysanthemum TCM materials with the aim of improving the quality of Wild Chrysanthemum commercial materials and meeting the needs of market transactions. They are also an important component of high-quality TCM materials. High-quality Wild Chrysanthemum TCM materials refer to those produced in accordance with management regulations such as the *Good Agricultural Practice for TCM Materials* (GAP) or the *Good Agricultural Practice for Medicinal Plants* (GACP), with quality indicators exceeding the current standards in the *Chinese Pharmacopoeia* and limit indicators for exogenous pollutants and endogenous toxic substances lower than those in the *Chinese Pharmacopoeia*. Additionally, specific techniques for enhancing exclusivity are added based on the specific varietie